does blue cross cover glp 1 drugs glp-1 for weight loss Blue Cross Blue Shield of Massachusetts will A handful of nonprofit Blue

Morgan Research forecasts that the GLP-1 market will exceed $100 bn by 2030, driven equally by diabetes and obesity usage

The Rise of DIY & Gray Market GLP-1 Sales Gray market GLP-1 drugs are often purchased from online vendors, overseas pharmacies, compounding labs, or social media sellers without FDA oversight

N Engl J Med 2023;388:117-27.ArticlePubMed 50

While Victoza may cause similar weight loss effects as Saxenda, it is not FDA-approved to treat obesity

Metabolic: Euglycemic DKA The risk of euglycemic DKA is very uncommon, but its a clinically important and real complication to be aware of in patients using GLP-1 agonists

However, due to its invasiveness, it should be offered preferentially to patients with exhausted non-pharmacological and pharmacological treatment options